Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZITHROMYCIN Cause Acute respiratory failure? 83 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Acute respiratory failure have been filed in association with AZITHROMYCIN (AZITHROMYCIN). This represents 0.5% of all adverse event reports for AZITHROMYCIN.

83
Reports of Acute respiratory failure with AZITHROMYCIN
0.5%
of all AZITHROMYCIN reports
42
Deaths
56
Hospitalizations

How Dangerous Is Acute respiratory failure From AZITHROMYCIN?

Of the 83 reports, 42 (50.6%) resulted in death, 56 (67.5%) required hospitalization, and 30 (36.1%) were considered life-threatening.

Is Acute respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does AZITHROMYCIN Cause?

Off label use (2,979) Drug ineffective (2,609) Drug hypersensitivity (1,978) Dyspnoea (1,409) Condition aggravated (1,063) Nausea (1,006) Asthma (972) Wheezing (951) Product use in unapproved indication (886) Cough (837)

What Other Drugs Cause Acute respiratory failure?

PREDNISONE (645) TREPROSTINIL (484) MACITENTAN (422) TACROLIMUS (414) AMBRISENTAN (402) DEXAMETHASONE (384) RIVAROXABAN (361) RITUXIMAB (351) MYCOPHENOLATE MOFETIL (347) METHOTREXATE (321)

Which AZITHROMYCIN Alternatives Have Lower Acute respiratory failure Risk?

AZITHROMYCIN vs AZITHROMYCIN ANHYDROUS AZITHROMYCIN vs AZITHROMYCIN OR METHOTREXATE AZITHROMYCIN vs AZOSEMIDE AZITHROMYCIN vs AZTREONAM AZITHROMYCIN vs AZTREONAM LYSINE

Related Pages

AZITHROMYCIN Full Profile All Acute respiratory failure Reports All Drugs Causing Acute respiratory failure AZITHROMYCIN Demographics